NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/03/2024
Back to search
Official data from USPTO
TECHNOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TECHNOPHARMA
ST13
US500000076520172Class
3, 5
Filing
76520172
Registration
2960362
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
12/03/2024
Trademark type
Word
Nice classes
3, 5
Filing date
05/27/2003
Registration date
06/07/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2001-08-00
First use in commerce
2003-01-00
Drawing code
1
Owner type
03
Owner location
SURBITON, GB
Examiner
COGGINS,ROBERT H
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TECHNOPHARMA LIMITED
Peter Nailsworth Pharmaceuticals, Ltd.
Representatives
David M. Rogero David M. Rogero, P.A.
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
cosmeticssoapsbody and face creamsbody and face lotions
Class 5
over-the-counter and prescription pharmaceutical dermatologicals
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/03/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/03/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/11/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/27/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
08/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/11/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/07/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/10/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/10/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/10/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
07/23/2014
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/18/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/18/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/18/2011
E815
TEAS SECTION 8 & 15 RECEIVED
06/07/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2005
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/18/2005
ALIE
ASSIGNED TO LIE
02/18/2005
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/16/2005
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/16/2005
PAPER RECEIVED
01/21/2005
IUAF
USE AMENDMENT FILED
01/20/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/20/2004
PUBO
PUBLISHED FOR OPPOSITION
04/27/2004
NPUB
NOTICE OF PUBLICATION
04/07/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2004
PAPER RECEIVED
01/23/2004
CNRT
NON-FINAL ACTION MAILED
11/10/2003
DOCK
ASSIGNED TO EXAMINER
11/09/2003
Continuous trademark protection
Get notified about every new filing that threatens TECHNOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.